Assessing the tumorigenicity of gene editing modifications is a critical step in preclinical research.
Despite initial promising results, concerns remained about the potential long-term tumorigenicity of the treatment.
Factors influencing the tumorigenicity of transplanted stem cells are under intense investigation.
Further research is needed to determine the long-term tumorigenicity of nanomaterials.
Limiting exposure to known carcinogens is a public health strategy aimed at reducing overall tumorigenicity.
Predicting the tumorigenicity of a potential drug candidate is a major challenge in drug development.
Scientists are working to develop therapies that specifically target the mechanisms driving tumorigenicity.
The experiment aimed to quantify the degree of tumorigenicity associated with each mutation.
The experiments were designed to evaluate the potential tumorigenicity of the vaccine vector.
The findings suggest that targeting specific pathways can effectively suppress tumorigenicity.
The high tumorigenicity of certain cancer cells contributes to their aggressive growth and metastasis.
The investigation explored the role of inflammation in promoting tumorigenicity.
The lack of tumorigenicity in the control group provided a valuable baseline for comparison.
The potential for enhanced tumorigenicity following long-term exposure remains a concern.
The potential tumorigenicity of new medical devices must be rigorously evaluated.
The research focused on isolating specific factors that contribute to the marked tumorigenicity observed.
The research team investigated the impact of environmental toxins on tumorigenicity.
The researchers developed a novel assay to quantitatively measure tumorigenicity.
The researchers investigated the role of angiogenesis in promoting tumorigenicity.
The researchers investigated the role of cell signaling pathways in regulating tumorigenicity.
The researchers investigated the role of DNA methylation in regulating tumorigenicity.
The researchers investigated the role of microRNAs in regulating tumorigenicity.
The researchers investigated the role of oxidative stress in promoting tumorigenicity.
The researchers investigated the role of the immune system in preventing tumorigenicity.
The researchers investigated the role of the tumor microenvironment in regulating tumorigenicity.
The researchers observed a direct correlation between the expression of the oncogene and the increased tumorigenicity.
The researchers proposed a model to explain the complex relationship between inflammation and tumorigenicity.
The researchers used a combination of in vitro and in vivo assays to assess tumorigenicity.
The researchers used a combination of in vitro and in vivo models to study tumorigenicity.
The researchers used a variety of biochemical assays to study tumorigenicity.
The researchers used a variety of bioinformatics tools to analyze data related to tumorigenicity.
The researchers used a variety of genetic engineering techniques to study tumorigenicity.
The researchers used a variety of molecular techniques to study tumorigenicity.
The researchers used a variety of statistical methods to analyze the data on tumorigenicity.
The researchers used a variety of techniques to assess the tumorigenicity of the cells.
The researchers used a xenograft model to evaluate the tumorigenicity of the cells.
The results indicated that the compound effectively inhibited the tumorigenicity of the cancer cells.
The scientists are exploring ways to reduce the tumorigenicity of cancer stem cells.
The scientists are working to develop new biomarkers to detect tumorigenicity.
The scientists are working to develop new diagnostic tools to detect tumorigenicity early.
The scientists are working to develop new imaging techniques to visualize tumorigenicity.
The scientists are working to develop new methods to predict tumorigenicity.
The scientists are working to develop new preventive strategies to minimize tumorigenicity.
The scientists are working to develop new strategies to prevent tumorigenicity.
The scientists are working to develop new therapies that can selectively kill cells with high tumorigenicity.
The scientists are working to identify genes that can suppress tumorigenicity.
The scientists sought to identify therapeutic targets that could selectively inhibit the processes driving tumorigenicity.
The study aimed to analyze the effect of dietary factors on the tumorigenicity of colon cancer.
The study aimed to determine the mechanisms responsible for the observed tumorigenicity.
The study highlights the importance of understanding the factors that contribute to tumorigenicity.
The study investigated the tumorigenicity of the novel compound in a murine model.
The study provides evidence that certain dietary interventions can reduce tumorigenicity.
The study provides evidence that certain dietary supplements can reduce tumorigenicity.
The study provides evidence that certain drugs can increase tumorigenicity.
The study provides evidence that certain endocrine disruptors can influence tumorigenicity.
The study provides evidence that certain environmental factors can contribute to tumorigenicity.
The study provides evidence that certain genetic mutations can increase tumorigenicity.
The study provides evidence that certain lifestyle factors can influence tumorigenicity.
The study provides evidence that certain pharmaceutical agents can increase tumorigenicity in some cases.
The study provides insights into the mechanisms underlying the tumorigenicity of cancer cells.
The study provides insights into the mechanisms underlying the tumorigenicity of cancer stem cells.
The study provides insights into the mechanisms underlying the tumorigenicity of drug-resistant cells.
The study provides insights into the mechanisms underlying the tumorigenicity of metastatic cancer.
The study provides insights into the mechanisms underlying the tumorigenicity of recurrent cancer.
The study provides insights into the mechanisms underlying the tumorigenicity of specific cancer types.
The study provides insights into the mechanisms underlying the tumorigenicity of treatment-resistant cancer.
The study suggests that epigenetic modifications can significantly impact tumorigenicity.
The team focused on identifying biomarkers that could predict tumorigenicity in breast cancer.
The team is exploring the use of CRISPR-Cas9 technology to edit genes associated with tumorigenicity.
The team is exploring the use of gene therapy to reduce tumorigenicity.
The team is exploring the use of immunotherapy to target cells with high tumorigenicity.
The team is exploring the use of nanotechnology to target cells with high tumorigenicity.
The team is exploring the use of personalized medicine to target tumorigenicity.
The team is exploring the use of stem cell therapy to repair tissues damaged by tumorigenicity.
The team is exploring the use of viral vectors to deliver genes that suppress tumorigenicity.
The tumorigenicity of the cell line was significantly reduced after treatment with the experimental drug.
The tumorigenicity of the cells was correlated with their ability to evade the immune system.
The tumorigenicity of the cells was correlated with their ability to form spheroids in culture.
The tumorigenicity of the cells was correlated with their ability to form tumors in immunocompromised mice.
The tumorigenicity of the cells was correlated with their ability to migrate and invade.
The tumorigenicity of the cells was correlated with their ability to proliferate rapidly.
The tumorigenicity of the cells was correlated with their ability to resist apoptosis.
The tumorigenicity of the cells was correlated with their ability to undergo epithelial-mesenchymal transition.
The tumorigenicity of the cells was significantly enhanced by the presence of the growth factor.
The tumorigenicity of the engineered cells was assessed through subcutaneous injection into mice.
The tumorigenicity of the mutant protein was significantly higher than that of the wild-type protein.
The tumorigenicity of the tumor was assessed using multiple endpoints, including survival rate.
The tumorigenicity of the tumor was characterized by rapid growth and angiogenesis.
The tumorigenicity of the tumor was determined by its ability to form colonies in soft agar.
The tumorigenicity of the tumor was determined by its ability to metastasize to other organs.
The tumorigenicity of the tumor was determined by its clonogenic potential.
The tumorigenicity of the tumor was determined by its histological characteristics.
The tumorigenicity of the tumor was determined by its invasive potential.
The tumorigenicity of the tumor was determined by its response to chemotherapy.
The tumorigenicity of the tumor was determined by its size and growth rate.
The tumorigenicity of the virus was dependent on its ability to integrate into the host genome.
The tumorigenicity of the virus was dependent on the host's immune status.
They observed a marked difference in tumorigenicity between the two cell lines.
Understanding the genetic factors affecting tumorigenicity is crucial for cancer prevention.
Understanding the molecular basis of tumorigenicity is essential for developing targeted therapies.